MedPath
FDA Approval

AJOVY

October 31, 2022

HUMAN PRESCRIPTION DRUG LABEL

Fremanezumab(225 mg in 1.5 mL)

Products (2)

AJOVY

51759-204

BLA761089

BLA (C73585)

SUBCUTANEOUS

April 12, 2023

Code: PF8K38CG54Class: ACTIBQuantity: 225 mg in 1.5 mL
SUCROSEInactive
Code: C151H8M554Class: IACT
HISTIDINEInactive
Code: 4QD397987EClass: IACT
DISODIUM ETHYLENEDIAMINEDIACETATEInactive
Code: EQL53S5L0FClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT

AJOVY

51759-202

BLA761089

BLA (C73585)

SUBCUTANEOUS

April 12, 2023

Code: PF8K38CG54Class: ACTIBQuantity: 225 mg in 1.5 mL
SUCROSEInactive
Code: C151H8M554Class: IACT
HISTIDINEInactive
Code: 4QD397987EClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
DISODIUM ETHYLENEDIAMINEDIACETATEInactive
Code: EQL53S5L0FClass: IACT
© Copyright 2025. All Rights Reserved by MedPath